AMGEN TO PRESENT AT GOLDMAN SACHS 45TH ANNUAL GLOBAL HEALTHCARE CONFERENCE

Rhea-AI Summary

Amgen (NASDAQ: AMGN) will be presenting at the Goldman Sachs 45th Annual Global Healthcare Conference. The presentation is scheduled for June 10, 2024, at 9:20 a.m. ET. Key speakers include Peter Griffith, executive vice president and CFO, and Jay Bradner, executive vice president of R&D and chief scientific officer. The presentation will be webcast live and archived for replay on Amgen's website for at least 90 days. This offers insights into Amgen's ongoing business developments and is accessible to media, investors, and the general public.

Positive

• Amgen's participation in a high-profile event increases visibility and investor interest.
• Live webcast and 90-day replay availability enhances accessibility and transparency.
• Key executives presenting can provide valuable insights into financial and R&D strategies.

Negative

• No new product launches or financial data updates were announced.
• Potential for stock volatility if the presentation does not meet investor expectations.
• Costs associated with participating in high-profile conferences could impact short-term finances.

THOUSAND OAKS, Calif., June 5, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the Goldman Sachs 45^th Annual Global Healthcare Conference at 9:20 a.m. ET on Monday, June 10, 2024. Peter Griffith, executive vice president and chief financial officer at Amgen, and Jay Bradner, executive vice president of Research and Development and chief scientific officer at Amgen, will present at the conference. The webcast will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public.

The webcast, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's website, www.amgen.com, under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event.

About Amgen 
Amgen discovers, develops, manufactures and delivers innovative medicines to help millions of patients in their fight against some of the world's toughest diseases. More than 40 years ago, Amgen helped to establish the biotechnology industry and remains on the cutting-edge of innovation, using technology and human genetic data to push beyond what's known today. Amgen is advancing a broad and deep pipeline that builds on its existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases.

In 2024, Amgen was named one of the "World's Most Innovative Companies" by Fast Company and one of "America's Best Large Employers" by Forbes, among other external recognitions. Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average^®, and it is also part of the Nasdaq-100 Index^®, which includes the largest and most innovative non-financial companies listed on the Nasdaq Stock Market based on market capitalization.

For more information, visit Amgen.com and follow Amgen on X, LinkedIn, Instagram, TikTok, YouTube and Threads. 

CONTACT: Amgen, Thousand Oaks
Elissa Snook, 609-251-1407 (media)
Justin Claeys, 805-313-9775 (investors)  

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/amgen-to-present-at-goldman-sachs-45th-annual-global-healthcare-conference-302164003.html

SOURCE Amgen

FAQ

When will Amgen present at the Goldman Sachs Global Healthcare Conference?

Amgen will present on June 10, 2024, at 9:20 a.m. ET.

Who will represent Amgen at the Goldman Sachs 45th Annual Global Healthcare Conference?

Peter Griffith, EVP and CFO, and Jay Bradner, EVP of R&D and chief scientific officer, will represent Amgen.

How can I access the Amgen presentation at the Goldman Sachs conference?

The presentation will be webcast live on Amgen's website and archived for replay for at least 90 days.

What is the significance of Amgen's presentation at the Goldman Sachs conference?

The presentation provides insights into Amgen's financial and R&D strategies and increases visibility among investors.

What is the stock symbol for Amgen?

The stock symbol for Amgen is AMGN.